Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials.
Li J, Yuan H, Bai Y, Pu C, Tang Y, Dong Q, Wei Q, Han P.
Li J, et al.
Clin Ther. 2014 Dec 1;36(12):2003-2014. doi: 10.1016/j.clinthera.2014.09.011. Epub 2014 Oct 16.
Clin Ther. 2014.
PMID: 25438723
PURPOSE: Dapoxetine is the first oral agent approved for the treatment of premature ejaculation (PE). ...The goal of this meta-analysis was to provide more information about the efficacy and safety of dapoxetine in patients with PE. METHODS: We perform …
PURPOSE: Dapoxetine is the first oral agent approved for the treatment of premature ejaculation (PE). ...The goal of th …